AKT1 and urinary bladder carcinoma: This suggests a specific effect of urolithin A. Our results are consistent with a study in bladder cancer cells showing that only urolithin A statistically significantly inhibited the phosphorylation of Akt compared to controls, while urolithin B and C did not cause any changes [53].